skip to Global Navigation Bar skip to main content


homeHome > About Us > Press Release > News

News

News Content
Daewoong Pharmaceuticals holds a symposium to promote the excellence of Olmesartan medications including ‘Olmetec’ at International Society of Hypertension
Date 2016-09-28 Hit 17610
list
News List
Prev Daewoong Pharmaceuticals expands entry to new markets with license in Mexico and India on Nabota
Next Daewoong Pharmaceutical presents its research results on ‘treatments for fibrosis and autoimmune disease’ at ACR